A clinical study to evaluate the role of MEDITATION (MINDFUL HAPPINESS) as an adjunct therapy in asymptomatic and mildly symptomatic covid-19 confirmed cases

Sonalika Social development Society0 个研究点目标入组 41 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Male female subjects of age group between 18 â?? 60 years
•2.Subjects who are COVID-19 confirmed cases, with mild severity presenting with signs and symptoms qualifying for low clinical risk (NEWS scoring 0-4)
•3.Subjects with SARS-CoV-2 RT-PCR confirmed COVID-19 positive with 72 hours from symptom onset or patient within 48 hours after laboratory diagnosis (SARS-CoV-2 RT-PCR)
•4.Subjects who are literate in English
•5.Female of childbearing potential willing to follow reliable and strict contraceptive measures
•6.Subjects judged to be reliable for compliance for performing meditation and capable of recording the effects of the meditation and motivated in receiving benefits from the meditation and compliance to quarantine procedure (as per prevailing guidelines)
•7.Willingness to provide written inform consent to participate in the study

•1.Confirmed COVID-19 positive cases with NEWS scoring system >= 5
•2.Individual with acute respiratory distress presenting with RR >24/minute, SaO2/SPO2<=94 % in room air condition, or the PaO2/FiO2 ratio <300mgHg
•3.Those who are regular practitioners of pranayama or meditation, defined as practicing any method of pranayama or meditation or both for at least 50 % of days in the last 1-month period
•4.Pregnant and breast-feeding females
•5.Recent history of significant lung disease like Asthma or Chronic Obstructive Lung Disease (COPD).
•6.Those who have pre-existing severe mental illnesses such as Bipolar disorder or schizophrenia
•7.Severe sleep problems defined as less than 3 hours of sleep every day for the preceding 7 days
•8.Suffering from Immunocompromising conditions or taking any immunosuppressing therapy
•9.Subjects suffering from severe and uncontrolled metabolic, endocrinal, cardiac/ renal/liver disease.
•10.The subject who are unable or unwilling to comply fully with the study protocol.
•11.Physician makes a decision that trial involvement is not in patientâ??s best interest, or any condition that does not allow the protocol to be followed safely.

发起方

Sonalika Social development Society